Available in 1.25 mg, 2.5 mg and 5 mg in bottles of 84 tablets.
Proven effectiveness for the treatment of canine congestive heart failure (CHF).
Registered for treatment of preclinical dilated cardiomyopathy (DCM) in large breeds
It is well-established* that pimobendan can be used as part of a CHF management program with a diuretic and an ACE-inhibitor, at the prescribing veterinarian’s discretion.
*Riviere J.E and Papich M.G Veterinary Pharmacology and Therapeutics Ninth Edition 2009 Iowa, Blackwell Publishing
What is CorMedin®?
CorMedin is a pimobendan product available in 1.25 mg, 2.5 mg and 5 mg sizes. CorMedin can be used to treat canine congestive heart failure (CHF) originating from dilated cardiomyopathy (DCM) or valvular insufficiency (mitral and / or tricuspid regurgitation).
How does it work?
Pimobendan has a dual action mechanism. It exhibits positive inotropic effects through sensitisation of the cardiac muscle to calcium, allowing cardiac contractions to be more efficient without utilising additional oxygen. Pimobendan also inhibits the action of phosphodiesterase (type III) in vascular smooth muscle, resulting in vasodilation, helping to reduce workload on the heart.
Offer Your Clients the Best Tools for Compliance
Send your client home with and help them stay on top of their medication with the Heart Health Kit & Heart Health for Dogs App
Furosemide is an efficient diuretic which increases the urinary excretion of water, sodium, chloride and potassium. It acts primarily by affecting sodium resorption in the loop of Henle. Diuretic effects may occur within one hour after oral dosing, and peak effects within two hours.